Finanzwire Finanzwire
Basculer en Français
11152 Companies
246103 Keywords
174094 Articles
132859 Press releases
Headlines Articles Press releases Jaguar Health Remove
  1. Home
  2. Companies
  3. Jaguar Health
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/18/2024 at 16:35, 2 years 2 months ago

    Jaguar Health to Report Phase 3 OnTarget Trial Results for Crofelemer on July 23rd

    Crofelemer Webcast Jaguar Health OnTarget Trial Cancer Supportive Care
  • PRESS RELEASE

    published on 07/18/2024 at 16:30, 2 years 2 months ago

    Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning

    Jaguar Health announces webcast for cancer supportive care updates including OnTarget trial results. Make Cancer Less Shitty program expands with MCLS Ambassadors
    Webcast Jaguar Health OnTarget Trial Cancer Supportive Care Make Cancer Less Shitty
    Logo of Jaguar Health
  • BRIEF

    published on 07/08/2024 at 16:35, 2 years 3 months ago

    Jaguar Health Strengthens IP Protection with New European and Australian Patents

    Crofelemer Jaguar Health Australian Patent European Patent SBS And CDDs
  • PRESS RELEASE

    published on 07/08/2024 at 16:30, 2 years 3 months ago

    Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)

    New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025
    Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease
    Logo of Jaguar Health
Previous page
1 2
Accesswire
  • Published on 10/09/2026 at 14:00, 4 hours 33 minutes ago

    Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence

  • Published on 10/09/2026 at 14:00, 4 hours 33 minutes ago

    Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

  • Published on 10/09/2026 at 13:23, 5 hours 10 minutes ago

    SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO

  • Published on 10/09/2026 at 13:00, 5 hours 33 minutes ago

    Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development

  • Published on 10/09/2026 at 13:00, 5 hours 33 minutes ago

    Nepra Foods Launches Flagship PROPASTA Brand on Amazon

View all ACCESSWIRE
EQS Group
  • Published on 10/09/2026 at 18:00, 33 minutes ago

    ARVERNE GROUP: Arverne reaches a major milestone: Europe recognizes the Lithium de France Project as a pillar of its industrial sovereignty

  • Published on 10/09/2026 at 18:00, 33 minutes ago

    Private Equity Holding AG: Net Asset Value as of September 30, 2026

  • Published on 10/09/2026 at 17:15, 1 hour 18 minutes ago

    OPPO Find X10 Pro Max to Debut Globally with MediaTek’s 2nm Flagship Dimensity 9600 Pro

  • Published on 10/09/2026 at 17:10, 1 hour 22 minutes ago

    "Soaring Creativity - Hong Kong Pavilion" Returns to Frankfurt Book Fair 2026, Showcasing Over 1,000 Masterpieces

  • Published on 10/09/2026 at 16:30, 2 hours 3 minutes ago

    Novem Group S.A.: Changes in Management Board

View all EQS
Les Echos
  • Published on 10/09/2026 at 18:01, 32 minutes ago

    Title of my press release

  • Published on 10/08/2026 at 18:30, 1 day ago

    Cegedim: Release of its 2026 Interim Financial Report

  • Published on 10/08/2026 at 18:00, 1 day ago

    Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years

  • Published on 10/08/2026 at 17:45, 1 day ago

    Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain

  • Published on 10/07/2026 at 18:19, 2 days ago

    Outstanding shares and voting rights statement at 30 September 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy